| Formulary Chapter 4: Central nervous system - Full Chapter
|
| 04.09.01 |
Dopaminergic drugs used in Parkinsons disease |
|
|
| 04.09.01 |
Dopamine receptor agonists |
|
|
Rotigotine
(patch)
|
Formulary
|
Initiated/recommended by specialists only.
A replacement for oral dopamine agonists in patients with inadequate control of nocturnal/early morning symptoms.
In patients with inadequate compliance of complex regimens (cognitive problems, unable to swallow oral medication, motor problems).
As sole treatment in emergency situations when patients are unable to swallow oral drugs
|
| 04.09.01 |
Monoamine-oxidase-B inhibitors |
|
|
| 04.09.01 |
Catachol-O-methyltransferase inhibitors |
|
|
Key |
|
|
|
|
Cytotoxic Drug
|
|
|
Controlled Drug
|
|
High Cost Medicine
|
|
Traffic Light Status Information
| Status |
Description |
|
Suitable for prescribing by all in both primary and secondary care. |
|
Specialist recommended but suitable for continuation in primary care. |
|
Specialist initiated but suitable for continuation in primary care. |
|
Specialist initiated and for continuation in primary care under a locally approved shared care guideline. |
|
Suitable for prescribing in specialist settings (secondary care) only. |
|
Secondary care medicines to be used under specialised commissioning arrangements only. |
|
For primary care, either via FP10 or supplied through specialist services. These products may be stocked by hospital
pharmacies only for supply to primary care units/wards or for continuing supplies for patients admitted on therapy. |
|
Not recommended for use. |
|
|
